We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

37 hedge funds and large institutions have $43.9M invested in InVivo Therapeutics Holdings Corp in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

438% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $879K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more funds holding

Funds holding: 35 → 37 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

34% less capital invested

Capital invested by funds: $66.6M → $43.9M (-$22.7M)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
1
Closed
4
Calls
$4.73M
Puts
$879K
Net Calls
+$3.85M
Net Calls Change
+$4.41M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$3.04M
2
Northern Trust
Northern Trust
Illinois
+$2.57M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.1M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$4.01M
2
CSS
Cubist Systematic Strategies
Connecticut
-$344K
3
Jane Street
Jane Street
New York
-$277K
4
Bank of America
Bank of America
North Carolina
-$234K
5
EIM
Emerson Investment Management
Massachusetts
-$234K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$7.57M +$2.1M +9 +24%
WF
2
Welch & Forbes
Massachusetts
$6.67M – – –
BFA
3
BlackRock Fund Advisors
California
$5.91M – – –
BIT
4
BlackRock Institutional Trust
California
$4.84M +$3.04M +13 +76%
State Street
5
State Street
Massachusetts
$2.84M +$935K +4 +29%
Northern Trust
6
Northern Trust
Illinois
$2.34M +$2.57M +11 +367%
ICM
7
IMS Capital Management
Oregon
$2.01M +$701K +3 +33%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.43M +$2.1M +9 New
TCIM
9
TIAA CREF Investment Management
New York
$1.12M +$467K +2 +40%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$882K +$1.17M +5 New
BIM
11
BlackRock Investment Management
Delaware
$815K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$740K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$738K +$701K +3 +150%
Morgan Stanley
14
Morgan Stanley
New York
$698K – – –
California State Teachers Retirement System (CalSTRS)
15
California State Teachers Retirement System (CalSTRS)
California
$416K – – –
EIM
16
Emerson Investment Management
Massachusetts
$396K -$234K -1 -33%
Goldman Sachs
17
Goldman Sachs
New York
$379K +$234K +1 +100%
UBS Group
18
UBS Group
Switzerland
$334K +$234K +1 +100%
TA
19
Teachers Advisors
New York
$332K – – –
Citigroup
20
Citigroup
New York
$327K +$467K +2 New
Charles Schwab
21
Charles Schwab
California
$324K – – –
Stifel Financial
22
Stifel Financial
Missouri
$312K +$234K +1 +100%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$209K – – –
LPL Financial
24
LPL Financial
California
$203K – – –
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$198K – – –
1
2 3

NVIV Hedge Fund Activity: Q3 2015 in Review

37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q3 2015, worth a combined $43.9M — down 34% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.01M sold.

  • 37 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q3 2015, up from 35 in Q2 2015.
  • Funds reported $43.9M of InVivo Therapeutics Holdings Corp stock for Q3 2015, down 34% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q3 2015 and 4 closed out, a net change of +2 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $3.04M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q3 2015 was Bogle Investment Management, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2015.